Adicet bio appoints nancy boman, m.d., ph.d., as senior vice president and chief regulatory officer

Redwood city, calif. & boston--( business wire )--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer, today announced the appointment of nancy boman, m.d., ph.d., as senior vice president and chief regulatory officer. dr. boman will spearhead adicet's regulatory strategy to further advance existing and new pipeline opportunities for the company's gamma delta t cell platform.
ACET Ratings Summary
ACET Quant Ranking